GI Logic Receives FDA 510K Clearance for the AbStats™

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
GI Logic Receives FDA 510K Clearance for the AbStats™ System for Real-Time Digestive Telemetry

PASADENA, Calif., Dec. 18, 2015 (GLOBE NEWSWIRE) -- GI Logic, a privately held gastroenterology medical device company, announced today it has received FDA 510K clearance for the AbStats™ System to be used by physicians in hospitals and other healthcare settings for non-invasive, real time telemetry of the digestive system.

Recovery after surgery is frequently associated with diminished gastrointestinal function because anesthesia, pain medications and the surgery itself “shuts down” the digestive system. As a result, many post-operative patients suffer gastrointestinal dysfunction and cannot tolerate food until post-operative digestion is re-awakened. Physicians and nurses often struggle with the timing of feeding, as either feeding too early or too late can result in negative consequences for the patient. The AbStats System, consisting of two AbStats Vibratory Sensors placed on the abdomen and the AbStats Telemetry Monitor. The monitor allows care providers to see digestive signals as they occur and evaluate the rate of digestive activity. This rate can help doctors determine when the GI tract re-engages The data offers healthcare professionals objective data on which to base post-operative feeding protocols.

“Prior to the AbStats System, doctors and nurses had to essentially guess when a patient’s GI tract reengaged by asking the patient questions about their symptoms, and recovery. Often patients do not know the answers to the questions and the doctor and nurses are left to following their gut or very general guidelines on when to feed a patient,” said Brennan Spiegel, MD, Director of Health Services Research at Cedars-Sinai Health System and UCLA Professor of Medicine and Public Health, “In the two published trials in The Journal of Gastrointestinal Surgery, Spiegel BM, Kaneshiro M, Russell MM, el al. Validation of an acoustic gastrointestinal surveillance biosensor for postoperative ileus. J Gastrointest Surg 2014; 18: 1 795-803 and Kaneshiro M, Kaiser W, et al. Postoperative Gastrointestinal Telemetry with an Acoustic Biosensor Predicts Ileus vs. Uneventful GI Recovery. J Gastrointest Surg 2015; DOI 10.1007\s11605-015-2956-3, we demonstrated that AbStats is a valid measure of the intestinal engine – it can tell us whether the GI system is turned on or off, and when on, how fast it’s revving.  Our data showed that AbStats could predict which of our patients would get into trouble with post-operative feeding.”

Phillip Fleshner MD, Director Colorectal Surgery Research at Cedars-Sinai, had several patients in the study and finds the results intriguing. “There’s been no way to tag these patients or markers to guide our feeding decisions,” Fleshner said. “This device may fill that void by forecasting who will do well on advanced feeding schedules.”

“Digestive diseases are extraordinarily prevalent and expensive in the United States and beyond,” said Spiegel. “The cost of mismanaging post-operative feeding decisions, in particular, approaches $1 billion annually. As a health services researcher focused on maximizing the value of care, I view AbStats as a digital device with great potential to reduce costs while improving outcomes.  That’s the ultimate goal of the emerging digital health movement, and a rare opportunity for any single biosensor to achieve.”

“We are very pleased to have received this initial FDA 510K clearance for the AbStats System, the first easy-to-use, reliable digestive telemetry system for surgeons and gastroenterologist,” said James Beeton, co-founder and CEO of GI Logic.  “We will be introducing the AbStats System in the US in 2016 and plan to expand with additional indications and to additional markets following our successful introduction in the US market.” 

About GI Logic, Inc.

GI Logic, Inc. ( www.gi-logic.com ) develops and markets innovative diagnostic devices that record discrete abdominal sounds and vibrations giving physicians a non-invasive method for diagnosing diseases and conditions of the GI tract and the abdomen.  The company’s non-invasive technology is designed to detect and recognize changes in digestive tract movements, providing physicians with vital information about the functional status of the digestive system. This information will provide the physician the ability to make informed decisions and will allow the patient to receive a new level of care.

 

Contact James Beeton Co-founder & CEO 626-993-2772

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 627

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 245

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 311

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
LG's ASIL D Certification: A Game Changer in Autos

Updated Category News Views 150

Why LG's ASIL D Certification Matters There ain't much in the tangled mess of automotive innovations these days that'll make a seasoned investor raise an eyebrow, but here comes LG Electronics grabbing the ASIL D certification like it's a badge of market honor. The ISO 26262 ASIL D is no walk in the park, folks—it's the top rung on the safety ladder, something that's...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 364

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
CureGene's Evategrel Aims for Breakthrough in Stroke Care

Updated Category News Views 105

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 108

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 354

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
Fibocom Unveils U6G Solutions Advancing Global 5G Tech

Updated Category News Views 35

Breaking Barriers with U6G-Capable Technology Sneaking into the industry's spotlight at MWC Doha 2026, Fibocom flaunts a robust lineup of next-gen 5G solutions. It's as if they're shuffling every card they’ve got to win over the broadband world. With breakthroughs like the FG390, FG370, and FG670 modules, alongside PCBA-level innovations, Fibocom is not just throwing...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 364

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading

Top 5 Most Recently Viewed Articles

VIQ Solutions' Leadership Transition Marks New Era Ahead

Updated Category News Views 244

VIQ Solutions Marks a New Chapter with Leadership Changes VIQ Solutions Inc. is making noteworthy changes in its executive team that will undoubtedly shape the organization's path forward. The firm, known for being a global provider of AI-driven, secure digital voice and video capture technology, has announced the retirement of Susan Sumner, who has been a pivotal figure...

Continue Reading
Lucid Group's Fourth Quarter Success: Record Deliveries Ahead

Updated Category News Views 130

Lucid Group Inc Reports Strong Q4 Earnings Lucid Group Inc (NASDAQ: LCID) has revealed its fourth-quarter financial results, demonstrating a significant improvement in revenue and production metrics. The results were reported after the market closed on a recent Tuesday, showcasing the company's ongoing commitment to innovation in the electric vehicle sector. Revenue...

Continue Reading
Verily Sightline Collaborates with Bangor University in Europe

Updated Category News Views 149

Verily Partners with Bangor University for Wastewater Testing Verily, recognized for its precision health technology, is extending its wastewater surveillance program into Europe through a promising partnership with Bangor University. This collaboration aims to take advantage of the innovative wastewater-based public health programs at Bangor to enhance testing...

Continue Reading
Amaero's Strategic Supply Agreement Boosts U.S. Titanium Production

Updated Category News Views 213

Amaero Secures Strategic Long-Term Supply Agreement Significant Milestone in Domestic Supply Chain Development Amaero International Limited (ASX:3DA), a prominent U.S. manufacturer of high-quality titanium powders, has successfully signed a three-year Supply Agreement with The Perryman Company, a leader in titanium production. This agreement marks a pivotal moment in...

Continue Reading
NextPlat: Insights from Interim CEO on Future Directions

Updated Category News Views 132

NextPlat Corp's Interim CEO Update NextPlat Corp (NASDAQ: NXPL), a prominent player in the consumer products and services sector, recently issued a pivotal update from its interim CEO, David Phipps. This detailed letter serves as a roadmap to navigate the company’s future after the unexpected passing of its former CEO, Charles M. Fernandez. The focus is on leveraging...

Continue Reading